Provided is a prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection. A prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A prophylactic and/or therapeutic agent for a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A growth inhibitor for Porphyromonas gingivalis, comprising killed Enterococcus faecalis. An inhibitor for gingipain activity, comprising killed Enterococcus faecalis.
Provided is a viscous nutritional composition that can be used without effort two or three times per day by, for example, a patient undergoing rehabilitation or long-term treatment. This viscous nutritional composition contains nutrients that include proteins, lipids, and carbohydrates. The density (quantity of heat/g) of the viscous nutritional composition is 0.9–1.1 kcal/g, the quantity of heat per unit is 450–550 kcal/unit, and two or three units are to be used per person per day.
Provided is a liquid nutritional composition which is in a small volume, has high energy, and allows easy ingestion of a variety of nutrients such as protein, lipids, saccharides, dietary fiber, vitamins, minerals, and vitamin-like substances. Provided is a liquid nutritional composition which contains protein, fat, saccharides, and dietary fiber and has a calorie content of 1.7-2.3 kcal/mL, a viscosity at 25°C of 25-40 mPa·s, and an osmotic pressure of 420-500 mOsm/L, wherein: the composition contains 6.2-6.8 mass% of the protein, 6.4-7.0 mass% of lipids, 18-24 mass% of saccharides, and 1.5-2.5 mass% of dietary fiber; and the dietary fiber contains, in the total dietary fiber, 20-35 mass% of water-soluble dietary fiber, which has a weight average molecular weight of 15,000-25,000 and viscosity of a 5 mass% solution of 10 mPa·s or less.
Provided is a growth inhibitor for Clostridioides difficile. A growth inhibitor for Clostridioides difficile, comprising killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer or a detergent for inhibiting the growth of Clostridioides difficile.
Provided is an agent for the prevention and/or treatment of Porphyromonas gingivalis infection. An agent for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. An agent for the prevention and/or treatment of a disease caused by Porphyromonas gingivalis that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of a disease caused by of Porphyromonas gingivalis that contains killed Enterococcus faecalis. A Porphyromonas gingivalis growth inhibitor that contains killed Enterococcus faecalis. A gingipain activity inhibitor that contains killed Enterococcus faecalis.
Provided is an agent for the prevention and/or treatment of Porphyromonas gingivalis infection. An agent for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. An agent for the prevention and/or treatment of a disease caused by Porphyromonas gingivalis that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of a disease caused by of Porphyromonas gingivalis that contains killed Enterococcus faecalis. A Porphyromonas gingivalis growth inhibitor that contains killed Enterococcus faecalis. A gingipain activity inhibitor that contains killed Enterococcus faecalis.
Provided is a food material capable of preparing a mixer porridge-like food or a jelly thereof which is not subject to the formation of lumps (undissolved lumps of flour). Provided is granulated rice flour. The rice flour may be granulated together with a gelling agent and a starch degrading enzyme. A method for producing granulated rice flour includes spraying a liquid in which rice powder is dissolved to a mixture of rice powder, a gelling agent and a starch degrading enzyme. A food composition contains granulated rice flour. A mixer porridge-like food or a jelly thereof is obtained by dispersing granulated rice flour in a liquid.
In order to provide a nutritional composition that has a shape that is easy to administer or ingest, that does not exhibit a marked reduction in viscosity under acidity (when mixed with gastric juices), and that has excellent nutrients, the nutritional composition according to one embodiment of the present invention includes casein, collagen, and a thickener, where the thickener does not have a gelling property that is exhibited when cooled after heating, and is soluble in an acid.
A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
A23L 29/256 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
Provided is a Clostridiodes difficile growth inhibitor. A Clostridiodes difficile growth inhibitor containing killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer, or a detergent for inhibiting growth of Clostridiodes difficile.
A01N 63/20 - BacteriaSubstances produced thereby or obtained therefrom
A01P 1/00 - DisinfectantsAntimicrobial compounds or mixtures thereof
A61K 8/99 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61L 15/36 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
Provided is a Clostridiodes difficile growth inhibitor. A Clostridiodes difficile growth inhibitor containing killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer, or a detergent for inhibiting growth of Clostridiodes difficile.
A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
A61L 15/36 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
The present invention provides a dextrin powder at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. A dextrin powder obtainable by spray drying a dextrin solution, wherein dextrin particles with a length to thickness ratio of 3 or more are contained in a proportion of 3% or more (as based on the number of the particles). A thickener comprising the dextrin powder. A food comprising the dextrin powder.
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
A23F 3/14 - Tea preparations, e.g. using additives
Provided is a novel preventive and/or therapeutic agent for Clostridium difficile infection. It has been discovered that bacteria belonging to the genus Enterococcus are capable of preventing and/or curing Clostridium difficile infection. Disclosed herein are: an agent that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus; a medicinal product that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus; and a food product that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus.
Provided, at a low cost, is a dextrin powder that can be used as a component for a thickener having good dispersibility in water or the like. This dextrin powder is obtained by spray-drying a dextrin solution, the powder containing 3% or more dextrin particles (count-based ratio of particles) with a ratio of length over thickness of 3 or greater. Also provided is a thickener containing the dextrin powder and a food product containing the dextrin powder.
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
Provided, at a low cost, is a dextrin powder that can be used as a component for a thickener having good dispersibility in water or the like. This dextrin powder is obtained by spray-drying a dextrin solution, the powder containing 3% or more dextrin particles (count-based ratio of particles) with a ratio of length over thickness of 3 or greater. Also provided is a thickener containing the dextrin powder and a food product containing the dextrin powder.
A23L 29/30 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing carbohydrate syrupsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugarsFoods or foodstuffs containing additivesPreparation or treatment thereof containing sugar alcohols, e.g. xylitolFoods or foodstuffs containing additivesPreparation or treatment thereof containing starch hydrolysates, e.g. dextrin
The present invention provides dextrin particles at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. Fibrous dextrin particles. A thickener comprising the fibrous dextrin particles. A food comprising the fibrous dextrin particles. A method of preparing fibrous dextrin particles, comprising spray drying a dextrin solution with a viscosity of 100 mPa·s or more.
Provided is a novel agent for the prevention and/or treatment of Pseudomonas aeruginosa infection. It was discovered that bacteria belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. An agent for the prevention and/or treatment of Pseudomonas aeruginosa infection, the agent containing bacteria belonging to the genus Enterococcus. A medicine for the prevention and/or treatment of Pseudomonas aeruginosa infection, the medicine containing bacteria belonging to the genus Enterococcus. A food for the prevention and/or treatment of Pseudomonas aeruginosa infection, the food containing bacteria belonging to the genus Enterococcus.
Provided is a novel agent for the prevention and/or treatment of Pseudomonas aeruginosa infection. It was discovered that bacteria belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. An agent for the prevention and/or treatment of Pseudomonas aeruginosa infection, the agent containing bacteria belonging to the genus Enterococcus. A medicine for the prevention and/or treatment of Pseudomonas aeruginosa infection, the medicine containing bacteria belonging to the genus Enterococcus. A food for the prevention and/or treatment of Pseudomonas aeruginosa infection, the food containing bacteria belonging to the genus Enterococcus.
CA 03088601 2020-07-1534AbstractProvide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.Date Recue/Date Received 2020-07-15
Provided is a novel prophylactic and/or therapeutic agent for a pneumococcal infection. It is found that bacteria belonging to the genus enterococcus can prevent and/or treat a pneumococcal infection. Provided is a prophylactic and/or therapeutic agent for a pneumococcal infection, said agent containing bacteria belonging to the genus enterococcus. Provided is a prophylactic and/or therapeutic medicine for a pneumococcal infection, said medicine containing bacteria belonging to the genus enterococcus. Provided is a prophylactic and/or therapeutic food for a pneumococcal infection, said food containing bacteria belonging to the genus enterococcus.
Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus were found to be able to protect against MRSA infection. This MRSA infection protective agent contains bacteria belonging to the genus Enterococcus. Also provided are a medicine and a food, which are for protecting MRSA infection and contain bacteria belonging to the genus Enterococcus.
Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus were found to be able to protect against MRSA infection. This MRSA infection protective agent contains bacteria belonging to the genus Enterococcus. Also provided are a medicine and a food, which are for protecting MRSA infection and contain bacteria belonging to the genus Enterococcus.
Dextrin particles usable as a component of thickeners having satisfactory dispersibility in water, etc. are inexpensively provided. The present invention relates to: fibrous dextrin particles; a thickener comprising the fibrous dextrin particles; a food containing the fibrous dextrin particles; and a method for producing the fibrous dextrin particles which comprises spray-drying a dextrin solution having a viscosity of 100 mPa·s or higher.
Dextrin particles usable as a component of thickeners having satisfactory dispersibility in water, etc. are inexpensively provided. The present invention relates to: fibrous dextrin particles; a thickener comprising the fibrous dextrin particles; a food containing the fibrous dextrin particles; and a method for producing the fibrous dextrin particles which comprises spray-drying a dextrin solution having a viscosity of 100 mPa∙s or higher.
The present invention provides a gelling composition for preparing a gelatinous food which do not dissolve even when reheated (e.g., dysphagia diet).
The present invention provides a gelling composition for preparing a gelatinous food which retains its original shape even when reheated, wherein the gelling composition comprises a water-soluble polymer capable of forming a thermo-irreversible gel. Also provided is a method of gelling a food and enhancing the shape-retaining property of the food against reheating by using the above-described gelling composition, as well as a method of preparing a gelatinous food which retains its original shape even when reheated by using the above-described gelling composition.
A23L 29/20 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents
A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
A23L 29/212 - StarchModified starchStarch derivatives, e.g. esters or ethers
A23L 29/256 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
A23L 29/238 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
A23L 33/16 - Inorganic salts, minerals or trace elements
To provide a gelling composition for manufacturing a gelled foodstuff (e.g., deglutition adjustment food) that does not dissolve even when reheated. Provided is a gelling composition for manufacturing a gelled foodstuff that holds shape even when reheated after being manufactured, wherein the gelling composition contains a water-soluble polymer capable of forming a heat-irreversible gel. Also provided are a method for gelling a foodstuff and improving the ability of the foodstuff to retain shape in response to reheating after the foodstuff has been manufactured, and a method for manufacturing a gelled food item which holds shape even when reheated after being manufactured, using the gelling composition.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Dietary supplements for humans containing nutrients of
vitamins, minerals, etc. made mainly from Coenzyme Q10,
alpha lipoic acid, chromium, etc. in the form of pill,
granulated powder, capsule, powder, block, liquid, jelly or
paste; dietetic food adapted for medical purposes, namely
foodstuffs in the form of powder made mainly from
polysaccharide thickener and dextrin to add thickness for
patients with swallowing disorders.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Dietary supplements for humans; dietetic food adapted for
medical purposes, namely, foodstuffs in the form of powder
made mainly from polysaccharide thickener and dextrin to add
thickness for patients with swallowing disorders.
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
A23L 1/304 - Inorganic salts, minerals, trace elements
A23L 1/09 - containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin (A23L 1/76, A23L 1/236 take precedence);;
39.
Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Disclosed is an enteral nutritional composition which can save the effort of administrating dinking water between doses of the composition. The enteral nutritional composition comprises a protein, a carbohydrate and a lipid, has less than 1 kcal per mL, and has a water content of 30 mass% or more.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
COMPOSITION FOR REDUCING OXIDATIVE STRESS AND/OR SIDE EFFECTS OCCURRING DURING CANCER CHEMOTHERAPY OR IMPROVING NUTRITIONAL STATUS DURING CANCER CHEMOTHERAPY
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving a nutritional status during cancer chemotherapy. The composition is one for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12, and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.
Provided is a composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly. The composition is a composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant: (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B12; (d) zinc; and (e) selenium.
COMPOSITION FOR IMPROVING NUTRITIONAL STATUS OF THE ELDERLY, REDUCING FREQUENCY OF FEVER OF THE ELDERLY AND/OR INCREASING IMMUNOCOMPETENCE OF THE ELDERLY
Provided is a composition for improving thenutritional status, reducing the frequency of fever,and/or increasing the immunocompetence of the elderly.The composition is one for improving the nutritionalstatus, reducing the frequency of fever, and/orincreasing the immunocompetence of the elderly andcomprises the following components (a) to (e): (a) anantioxidant agent; (b) at least one component selectedfrom the group consisting of vitamin B1, vitamin B2,vitamin B6, niacin, and pantothenic acid; (c) at leastone component selected from the group consisting of folicacid and vitamin B12; (d) zinc; and (e) selenium.
COMPOSITION FOR REDUCING OXIDATIVE STRESS AND/OR SIDE EFFECTS OCCURRING DURING CANCER CHEMOTHERAPY OR IMPROVING NUTRITIONAL STATUS DURING CANCER CHEMOTHERAPY
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy. The composition is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant: (b) at least one component selected from the group consisting of vitamins B1, B2, B6, niacin and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12 and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.
Disclosed is a composition for reducing the level of glucose, a malondialdehyde-modified LDL, homocysteine and/or a C-reactive protein in the blood. Specifically disclosed is a composition for reducing the level of at least one substance selected from the group consisting of glucose, a malondialdehyde-modified LDL, homocysteine and a C-reactive protein in the blood, which comprises the following components (a) and (b): (a) at least one component selected from the group consisting of vitamin B12, vitamin B6 and folic acid; and (b) at least one component selected from the group consisting of zinc, selenium and an anti-oxidant vitamin.
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
